Richard R Drake Selected Research

Neoplasms (Cancer)

2/2024	Differential Protease Specificity by Collagenase as a Novel Approach to Serum Proteomics That Includes Identification of Extracellular Matrix Proteins without Enrichment.
1/2024	Spatial Omics Reveals that Cancer-Associated Glycan Changes Occur Early in Liver Disease Development in a Western Diet Mouse Model of MASLD.
1/2024	An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry.
1/2023	ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
11/2022	In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues.
10/2022	Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors.
1/2022	Novel Combined Enzymatic Approach to Analyze Nonsialylated N-Linked Glycans through MALDI Imaging Mass Spectrometry.
1/2022	Mass Spectrometry Imaging of N-Linked Glycans in a Formalin-Fixed Paraffin-Embedded Human Prostate by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization.
9/2021	Defining the Tumor Microenvironment by Integration of Immunohistochemistry and Extracellular Matrix Targeted Imaging Mass Spectrometry.
1/2021	Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard R Drake Research Topics

Disease

51	Neoplasms (Cancer) 02/2024 - 11/2002
27	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2006
12	Breast Neoplasms (Breast Cancer) 12/2022 - 05/2004
6	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 03/2005
5	Fibrosis (Cirrhosis) 02/2024 - 03/2005
5	Disease Progression 01/2024 - 01/2021
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2013
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2011
3	Nephritis 02/2022 - 06/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2018
3	Inflammation (Inflammations) 01/2019 - 12/2015
2	Liver Diseases (Liver Disease) 01/2024 - 03/2005
2	Neuroinflammatory Diseases 01/2024 - 05/2021
2	Lupus Nephritis 02/2022 - 06/2015
2	Ductal Carcinoma 07/2020 - 01/2019
2	Adenocarcinoma 01/2019 - 01/2017
2	Hyperplasia 01/2019 - 04/2015
2	Carcinogenesis 01/2016 - 04/2015
2	Obesity 08/2014 - 05/2009
2	Prostatic Diseases 04/2012 - 08/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2008 - 01/2005
2	Squamous Cell Carcinoma of Head and Neck 01/2008 - 01/2005
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Carcinoma (Carcinomatosis) 01/2023
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2022
1	Bone Neoplasms (Bone Cancer) 11/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2022
1	Ischemia 11/2022
1	Ocular Hypertension (Glaucoma, Suspect) 11/2022
1	Wounds and Injuries (Trauma) 11/2022
1	Primary Graft Dysfunction 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Heart Failure 01/2021
1	Glycogen Storage Disease (Glycogenosis) 01/2021
1	Congenital Disorders of Glycosylation 07/2020
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2020

Drug/Important Bio-Agent (IBA)

37	Polysaccharides (Glycans)IBA 01/2024 - 06/2011
29	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2004
29	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2004
8	Formaldehyde (Formol)FDA Link 11/2023 - 01/2014
6	Glycoproteins (Glycoprotein)IBA 07/2020 - 02/2009
5	Blood Proteins (Serum Proteins)IBA 05/2009 - 01/2004
4	ParaffinIBA 11/2023 - 01/2019
4	Mannose (D-Mannose)IBA 01/2023 - 01/2019
4	GlycosphingolipidsIBA 02/2022 - 06/2015
4	CollagenIBA 01/2022 - 01/2019
4	AntigensIBA 01/2021 - 01/2014
4	Peptides (Polypeptides)IBA 01/2021 - 05/2009
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 02/2009
3	EnzymesIBA 01/2023 - 08/2014
3	SphingolipidsIBA 11/2022 - 08/2014
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
3	CarbohydratesIBA 01/2021 - 10/2011
3	ProteomeIBA 01/2021 - 12/2012
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2020 - 12/2015
3	SphingosineIBA 12/2015 - 01/2013
3	CeramidesIBA 01/2015 - 01/2013
3	prostatic acid phosphataseIBA 10/2013 - 02/2009
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023 - 03/2019
2	GlycogenIBA 11/2022 - 01/2021
2	polylactosamineIBA 01/2021 - 01/2019
2	LectinsIBA 01/2021 - 10/2006
2	AcetylglucosamineIBA 01/2021 - 10/2013
2	CholesterolIBA 01/2020 - 01/2019
2	FucoseIBA 05/2019 - 03/2019
2	Phosphotransferases (Kinase)IBA 12/2015 - 09/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 10/2013
1	AndrogensIBA 12/2023
1	Alkynes (Acetylenes)IBA 01/2023
1	AminesIBA 01/2023
1	AzidesIBA 01/2023
1	Biotin (Vitamin H)FDA Link 01/2023
1	CopperIBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	SialyltransferasesIBA 01/2023
1	StreptavidinIBA 01/2023
1	Retinaldehyde (Retinal)IBA 11/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2022
1	Prostaglandins DIBA 01/2022
1	ElastinIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	LipopolysaccharidesIBA 05/2021
1	Fluvastatin FDA Link 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	N-AcetylglucosaminyltransferasesIBA 01/2021
1	EpitopesIBA 01/2021
1	Cadherins (E-Cadherin)IBA 07/2020

Therapy/Procedure

11	Lasers (Laser) 01/2024 - 01/2004
8	Therapeutics 01/2023 - 11/2002
3	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 01/2020
2	Castration 12/2023 - 12/2015
2	Precision Medicine 10/2022 - 05/2011
2	Drug Therapy (Chemotherapy) 01/2013 - 05/2004